Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.66
-0.36 (-2.76%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $434.93 million as of July 17, 2026. Its market cap has increased by 33.19% in one year.
Market Cap
434.93M
Enterprise Value
251.04M
1-Year Change
33.19%
Ranking
Category
Stock Price
$12.66
ChartMarket Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $434.93M, a decrease of -80.47%. That is a compound annual growth rate of -12.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 434.93M | -4.65% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 472.38M |
| Sagimet Biosciences | 470.55M |
| Editas Medicine | 470.36M |
| Artiva Biotherapeutics | 466.45M |
| Ovid Therapeutics | 464.73M |
| Prothena Corporation | 448.14M |
| Cabaletta Bio | 445.14M |
| Prelude Therapeutics | 440.35M |